OPZELURA FDA approval date

The FDA approved OPZELURA on 21 Sep 2021.

FDA approval date
21 Sep 2021

Drug identity has not yet been verified against registry records

Also recorded as RUXOLITINIB PHOSPHATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-09-21DayOPZELURAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215309", "applicant_as_listed_by_fda": "INCYTE CORP", "brand_names": ["OPZELURA"], "active_ingredients": ["RUXOLITINIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210921", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026